Article Photos: Oklahoma Medicaid program to receive $700,000 from pharmaceutical company 1/3

Sanford C. Coats, center, U.S. attorney for the Western District of Oklahoma, announces at a press conference Tuesday in Oklahoma City that Wyeth Pharmaceuticals has agreed to pay $490.9 million to resolve criminal and civil liability for the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration.  At left is Jim Finch, FBI special agent in charge; at right is Winston Whittington, an agent with the Department of Health and Human Services Office of the Inspector General. PHOTO BY PAUL B. SOUTHERLAND, THE OKLAHOMAN. <strong>PAUL B. SOUTHERLAND - PAUL B. SOUTHERLAND</strong>